Surgical Glue Market
By End-User;
Hospitals, Ambulatory Surgical Centers and OthersBy Product;
Natural and Synthetic & Semi-SyntheticBy Application;
Central Nervous System Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Cosmetic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Surgical Glue Market Overview
Surgical Glue Market (USD Million)
Surgical Glue Market was valued at USD 2,509.44 million in the year 2024. The size of this market is expected to increase to USD 3,760.83 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.
Surgical Glue Market
*Market size in USD million
CAGR 6.0 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.0 % |
| Market Size (2024) | USD 2,509.44 Million |
| Market Size (2031) | USD 3,760.83 Million |
| Market Concentration | Medium |
| Report Pages | 314 |
Major Players
- Baxter
- B. Braun Melsungen AG
- Cardinal Health
- CR. Bard
- Johnson and Johnson
- OptMed, Inc
- Applied Medical Resources Corporation
- CryoLife
- Integra LifeSciences
- Medtronic
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Surgical Glue Market
Fragmented - Highly competitive market without dominant players
Surgical Glue Market is witnessing strong growth as medical facilities increasingly adopt tissue adhesives for wound closure and internal procedures. Nearly 55% of hospitals now use surgical glues as an alternative to sutures and staples due to their faster application and reduced scarring. Their role in improving patient recovery and lowering infection risks is driving widespread demand.
Preference for Minimally Invasive Solutions
The shift toward minimally invasive procedures has accelerated the adoption of surgical glues. Around 60% of surgical interventions today employ adhesives for sealing tissues, particularly in delicate surgeries. Their ability to provide secure closure without additional trauma makes them a preferred choice in modern healthcare.
Technological Advancements in Formulations
Innovations in biocompatible and bioresorbable glues are enhancing market growth. Nearly 45% of new product developments emphasize advanced formulations that improve bonding strength while reducing toxicity. These innovations are increasingly being tailored to specialized applications such as cardiovascular, orthopedic, and cosmetic surgeries.
Focus on Patient Outcomes and Safety
Surgical glues significantly contribute to reduced post-operative complications. Studies indicate that their use can lower wound infection rates by almost 35%, improving patient safety. Additionally, they shorten recovery time and minimize discomfort, reinforcing their role in delivering efficient and patient-friendly care.
Future Potential of the Market
With rising demand for next-generation wound closure technologies, the surgical glue market is set for substantial expansion. More than 50% of ongoing clinical studies in surgical innovations are focused on adhesive-based solutions, underlining their growing importance in shaping the future of medical procedures.
Surgical Glue Market Key Takeaways
-
Surgical glue market is projected to reach by 2030, growing at a rate of 7.27% from 2025 to 2030, driven by increasing surgical procedures and advancements in wound closure technologies.
-
Natural adhesives held 59.51% of the market share in 2024, while synthetic and semi-synthetic formulations are expected to grow at a rate of 13.25% through 2030, indicating a shift towards engineered adhesives with enhanced properties.
-
Cardiovascular surgeries captured 32.53% of the market revenue in 2024, highlighting the critical need for effective hemostasis in high-risk procedures.
-
Cosmetic surgery is advancing at a rate of 12.15% through 2030, reflecting the growing demand for aesthetic procedures and minimally invasive techniques.
-
Hospitals are the primary end-users, accounting for a significant portion of the market share, due to the high volume of complex surgeries performed in these settings.
-
North America is expected to maintain its dominance in the market, owing to a large patient population, well-established healthcare infrastructure, and high adoption of advanced surgical technologies.
-
Asia-Pacific is anticipated to witness the highest growth rate, driven by increasing healthcare investments, rising surgical volumes, and a growing awareness of advanced wound care solutions.
Surgical Glue Market Recent Developments
-
In January 2022, Chemence Medical, Inc. received FDA clearance to market the Exofin Precision Pen, a medical device for wound closure that enhances versatility, precision, and ease of topical skin adhesive application.
-
In February 2022, Futura Surgicare Pvt Ltd developed wound closure devices under brands like Dolphin Sutures, Dolphin Mesh, Dolphin Tapes, Dolphin Hemostat, and Dolphin Stapler.
Surgical Glue Market Segment Analysis
In this report, Surgical Glue Market has been segmented by End-User, Product, Application, and Geography. The market is growing due to the increasing adoption of minimally invasive surgeries, rising demand for effective wound closure solutions, and advancements in surgical glue technology for better patient outcomes.
Surgical Glue Market, Segmentation by End-User
The End-User segmentation includes Hospitals, Ambulatory Surgical Centers, and Others. These end-users play a crucial role in the adoption and utilization of surgical glue in various surgical procedures.
Hospitals
Hospitals are the primary end-users of surgical glue, using it for a wide range of surgeries, from general surgeries to specialized procedures. Surgical glue is increasingly used in hospitals due to its ease of use, effectiveness, and ability to reduce recovery times.
Ambulatory Surgical Centers
Ambulatory surgical centers (ASCs) use surgical glue in outpatient procedures, providing a quicker recovery process for patients. These centers commonly use surgical glue in minor and moderate surgeries, where wound closure and efficient healing are essential.
Others
Other end-users include specialty clinics, dental clinics, and veterinary practices. These settings also utilize surgical glue in various procedures to offer better wound closure and healing, improving patient care and reducing the risk of complications.
Surgical Glue Market, Segmentation by Product
The Product segmentation includes Natural and Synthetic & Semi-Synthetic surgical glues. These products differ in their composition and properties, offering varied solutions for different types of surgeries.
Natural
Natural surgical glues are derived from biological sources, such as fibrin and collagen. These glues are biocompatible and are often used in surgeries requiring minimal foreign material in the body. They are commonly used for soft tissue adhesion and wound sealing.
Synthetic & Semi-Synthetic
Synthetic and semi-synthetic surgical glues are chemically engineered to provide stronger adhesion and durability. They are used in a variety of surgical procedures, including high-tension applications, due to their versatility and strength.
Surgical Glue Market, Segmentation by Application
The Application segmentation includes Central Nervous System Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Cosmetic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries, and Others. These applications represent the diverse areas where surgical glue is used to promote wound healing and improve surgical outcomes.
Central Nervous System Surgeries
Surgical glue is used in central nervous system surgeries to seal wounds and aid in tissue repair. It is especially useful in neurosurgical procedures to provide a secure closure of incisions and prevent cerebrospinal fluid leaks.
General Surgeries
In general surgeries, surgical glue is used to close incisions or seal wounds after procedures like appendectomy, hernia repairs, and gallbladder removal. It is favored for its ease of use, quick application, and reduced scarring.
Cardiovascular Surgeries
Surgical glue is used in cardiovascular surgeries for sealing vascular tissues and preventing bleeding during and after surgeries like coronary artery bypass grafting (CABG) and valve replacements. Its application helps in reducing recovery times and minimizing complications.
Orthopedic Surgeries
Orthopedic surgeries, including joint replacements and bone fracture repairs, use surgical glue to seal soft tissues and wounds. It promotes faster healing, especially in minimally invasive procedures like arthroscopy.
Cosmetic Surgeries
In cosmetic and plastic surgeries, surgical glue is used to minimize scarring and provide a precise closure of skin incisions. It is commonly used in facelifts, liposuction, and breast augmentation surgeries for its aesthetic benefits.
Ophthalmic Surgeries
Ophthalmic surgeries, such as cataract removal and retinal repairs, utilize surgical glue to close small incisions or seal tissue. Its application in these delicate procedures ensures proper wound healing and reduces the risk of complications.
Urological Surgeries
In urological surgeries, such as kidney and bladder surgeries, surgical glue is used to seal incisions and help with the repair of tissues. It is essential in minimizing the risk of infection and reducing recovery times.
Pulmonary Surgeries
Pulmonary surgeries, including lung resections and pleural procedures, use surgical glue to seal air leaks and prevent post-surgical complications like pneumothorax. It helps ensure a secure closure of the pulmonary tissue.
Others
Other applications of surgical glue include dental surgeries, veterinary procedures, and emergency wound closures. These diverse applications reflect the versatility and wide-ranging benefits of surgical glue in medical and surgical settings.
Surgical Glue Market, Segmentation by Geography
In this report, Surgical Glue Market has been segmented by Geography into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Regions and Countries Analyzed in this Report
North America
North America is the leading market for surgical glue, driven by the high adoption of advanced surgical techniques, robust healthcare infrastructure, and increasing demand for minimally invasive surgeries in the region.
Europe
Europe is seeing steady growth in the surgical glue market, with rising demand for wound closure solutions, expanding healthcare facilities, and increasing emphasis on reducing recovery times and surgical complications.
Asia Pacific
Asia Pacific is expected to experience significant growth, supported by rising healthcare expenditures, increasing adoption of advanced surgical techniques, and growing awareness about the benefits of surgical glue in countries like China, India, and Japan.
Middle East & Africa
The Middle East & Africa market is gradually expanding, driven by improvements in healthcare infrastructure, increasing adoption of advanced surgical techniques, and growing demand for efficient wound closure products in countries like the UAE and Saudi Arabia.
Latin America
Latin America is witnessing moderate growth in the surgical glue market, with rising healthcare access, expanding awareness of advanced surgical treatments, and increasing demand for minimally invasive procedures in countries like Brazil and Mexico.
Surgical Glue Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Surgical Glue Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Growth in Elective Surgeries
- Rising Number of Surgical Procedures
- Increasing Incidence of Trauma and Accidents
-
Innovations and Improvements in Adhesive Materials: In recent years, the surgical glue market has witnessed remarkable innovations and improvements in adhesive materials, revolutionizing surgical procedures and patient outcomes. One notable advancement lies in the development of bioadhesives derived from natural sources such as proteins and polysaccharides. These biomimetic adhesives offer enhanced biocompatibility and reduced risk of adverse reactions, addressing concerns associated with traditional synthetic adhesives. Bioadhesives exhibit strong adhesive properties, enabling effective wound closure without the need for sutures or staples, thus facilitating quicker recovery and minimizing scarring for patients.
Nanotechnology has played a pivotal role in the enhancement of adhesive materials for surgical applications. Nano-engineered adhesives offer superior strength, flexibility, and tissue adherence, enabling precise wound closure even in challenging surgical scenarios. By leveraging nanomaterials, such as nanoparticles and nanofibers, adhesive formulations can achieve optimal tissue penetration and adhesion, ensuring secure wound closure while promoting natural healing processes. Nanotechnology facilitates the controlled release of therapeutic agents, enabling localized drug delivery to enhance wound healing and prevent infections, further augmenting the clinical utility of surgical adhesives.
Advancements in adhesive chemistry have led to the development of next-generation formulations with enhanced properties, including rapid curing, tunable mechanical strength, and biodegradability. These novel adhesive materials offer surgeons greater versatility and precision in wound closure, enabling minimally invasive procedures and reducing operative times. The integration of smart polymers and additives enables real-time monitoring of adhesive performance and tissue response, ensuring optimal healing outcomes. As the demand for minimally invasive surgical techniques continues to grow, ongoing research and innovation in adhesive materials are poised to drive further advancements in the global surgical glue market, improving patient care and surgical outcomes worldwide.
Restraints:
- Prevalence of Chronic Diseases
- Cost-effectiveness and Efficiency
- Reduced Surgery Time and Hospital Stay
-
Decreased Risk of Infections and Complications: The surgical glue market has seen significant growth, largely due to its capacity to decrease the risk of infections and complications associated with traditional wound closure methods such as sutures and staples. Surgical glues offer a less invasive alternative that minimizes tissue trauma and reduces the exposure of wounds to external contaminants. This is particularly crucial in surgical procedures where infection control is paramount. By forming a protective barrier over the wound, surgical glues effectively seal the incision site, preventing bacteria from entering and proliferating. This results in a lower incidence of post-operative infections, which is a major concern in hospital settings.
In addition to reducing infections, surgical glues also contribute to fewer complications during the healing process. The use of these adhesives can enhance wound healing by providing optimal moisture balance and reducing the need for frequent dressing changes. Unlike sutures, which may cause localized tissue damage and inflammation, surgical glues adhere gently to the skin, promoting a more natural healing environment. This leads to reduced scarring and faster recovery times for patients. The flexibility of surgical glues allows them to move with the body, maintaining the integrity of the wound closure even in areas subject to significant movement or tension.
The decreased risk of infections and complications associated with surgical glues has far-reaching implications for both patient outcomes and healthcare costs. By minimizing the need for additional treatments and hospital readmissions due to infections or wound dehiscence, surgical glues can significantly lower the overall burden on healthcare systems. This is especially important in low-resource settings where healthcare infrastructure may be limited. The efficiency and effectiveness of surgical glues in promoting safer and faster recovery make them an increasingly attractive option in surgical practice worldwide, driving the growth of the global surgical glue market.
Opportunities:
- Collaborations and Partnerships
- Strategic Alliances Between Key Players
- Enhanced Post-surgical Aesthetic Results
-
Research and Development Collaborations: Research and Development (R&D) collaborations play a pivotal role in advancing the field of surgical glue, a critical component in modern medical procedures. These collaborations often involve partnerships between pharmaceutical companies, medical device manufacturers, academic institutions, and research organizations. By pooling resources and expertise, these entities can accelerate innovation, improve the efficacy and safety of surgical glues, and bring novel products to market more efficiently.
One significant aspect of R&D collaborations in the global surgical glue market is the focus on biocompatible and bioresorbable materials. Researchers are continually exploring new biomaterials that can mimic the properties of human tissues while promoting wound healing and minimizing adverse reactions. Collaborations between material scientists, biologists, and medical professionals are essential in this endeavor, as they work together to develop formulations that meet the stringent requirements of surgical applications.
R&D collaborations also facilitate the integration of advanced technologies into surgical glue development. This includes the utilization of nanotechnology for precise delivery and targeting, as well as the incorporation of smart materials that can respond to physiological cues within the body. Collaborations with experts in nanomedicine, biomedical engineering, and drug delivery systems are driving innovation in this space, potentially revolutionizing surgical procedures by enabling more precise, minimally invasive techniques. R&D collaborations are instrumental in shaping the future of the global surgical glue market, driving advancements that enhance patient outcomes and transform surgical practices worldwide.
Surgical Glue Market Competitive Landscape Analysis
Surgical Glue Market is characterized by rapid growth, driven by advancements in medical adhesives and a rising preference for less invasive surgical procedures. Companies are focusing on collaborations and innovations to enhance their product portfolios and offer improved solutions, contributing to overall market growth.
Market Structure and Concentration
The Surgical Glue Market features a competitive landscape with a mix of well-established and emerging players. While key players focus on product differentiation, smaller companies leverage innovative technologies to carve out niches in specific applications, fostering healthy competition and market expansion.
Brand and Channel Strategies
Leading brands in the Surgical Glue Market utilize comprehensive channel strategies to enhance accessibility and brand recognition. Companies employ marketing campaigns and invest in digital platforms to broaden their market presence, connecting with healthcare providers and end-users more effectively.
Innovation Drivers and Technological Advancements
Innovation is at the core of the Surgical Glue Market, with companies focusing on the development of biocompatible adhesives and advancements in surgical techniques. These technological innovations are expected to improve the precision and safety of procedures, propelling market growth.
Regional Momentum and Expansion
Regional expansion strategies are pivotal for the growth of the Surgical Glue Market. Companies are focusing on emerging markets, particularly in Asia Pacific, where rising healthcare access and demand for advanced medical solutions are driving substantial market expansion and increased competition.
Future Outlook
The future of the Surgical Glue Market is poised for continued growth, driven by ongoing technological advancements and increased investment in research and development. Strong partnerships and strategic mergers will likely foster new product innovations, ensuring the market remains dynamic and competitive.
Key players in Surgical Glue Market include:
- Johnson & Johnson
- Baxter International
- B. Braun Melsungen
- C.R. Bard
- Medtronic
- CryoLife
- Integra LifeSciences
- Cardinal Health
- Becton Dickinson (BD)
- Mallinckrodt
- Cohera Medical
- Sanofi
- CSL Limited
- Stryker
- Ocular Therapeutix
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By End-User
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Region
- Surgical Glue Market Forces
- Drivers, Restraints and Opportunities
- Drivers
-
Growth in Elective Surgeries
-
Rising Number of Surgical Procedures
-
Increasing Incidence of Trauma and Accidents
-
Innovations and Improvements in Adhesive Materials
-
- Restraints
-
Prevalence of Chronic Diseases
-
Cost-effectiveness and Efficiency
-
Reduced Surgery Time and Hospital Stay
-
Decreased Risk of Infections and Complications
-
- Opportunities
-
Collaborations and Partnerships
-
Strategic Alliances Between Key Players
-
Enhanced Post-surgical Aesthetic Results
-
Research and Development Collaborations
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- CompetitiveRivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Surgical Glue Market, By End-User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Surgical Glue Market, By Product, 2021 - 2031 (USD Million)
- Natural
- Synthetic & Semi-Synthetic
- Surgical Glue Market, By Application, 2021 - 2031 (USD Million)
- Central Nervous System Surgeries
- General Surgeries
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Cosmetic Surgeries
- Ophthalmic Surgeries
- Urological Surgeries
- Pulmonary Surgeries
- Others
- Surgical Glue Market, By Geography, 2021 - 2031 (USD Million)
-
North America
-
United States
-
Canada
-
-
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Nordic
-
Benelux
-
Rest of Europe
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia & New Zealand
-
South Korea
-
ASEAN (Association of South East Asian Countries)
-
Rest of Asia Pacific
-
-
Middle East & Africa
-
GCC
-
Israel
-
South Africa
-
Rest of Middle East & Africa
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Rest of Latin America
-
-
- Surgical Glue Market, By End-User, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Johnson & Johnson
- Baxter International
- B. Braun Melsungen
- C.R. Bard
- Medtronic
- CryoLife
- Integra LifeSciences
- Cardinal Health
- Becton Dickinson (BD)
- Mallinckrodt
- Cohera Medical
- Sanofi
- CSL Limited
- Stryker
- Ocular Therapeutix
- Company Profiles
- Analyst Views
- Future Outlook of the Market

